Outcome measurement in functional neurological disorder: a systematic review and recommendations
-
Published:2020-02-28
Issue:6
Volume:91
Page:638-649
-
ISSN:0022-3050
-
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
-
language:en
-
Short-container-title:J Neurol Neurosurg Psychiatry
Author:
Pick SusannahORCID, Anderson David G, Asadi-Pooya Ali AORCID, Aybek SelmaORCID, Baslet Gaston, Bloem Bastiaan RORCID, Bradley-Westguard Abigail, Brown Richard JORCID, Carson Alan JORCID, Chalder TrudieORCID, Damianova Maria, David Anthony SORCID, Edwards Mark JORCID, Epstein Steven A, Espay Alberto JORCID, Garcin BéatriceORCID, Goldstein Laura HORCID, Hallett MarkORCID, Jankovic JosephORCID, Joyce Eileen MORCID, Kanaan Richard AORCID, Keynejad Roxanne CORCID, Kozlowska KasiaORCID, LaFaver KathrinORCID, LaFrance, Jr. W CurtORCID, Lang Anthony EORCID, Lehn AlexORCID, Lidstone SarahORCID, Maurer Carine WORCID, Mildon BridgetORCID, Morgante FrancescaORCID, Myers LornaORCID, Nicholson ClareORCID, Nielsen GlennORCID, Perez David LORCID, Popkirov StoyanORCID, Reuber MarkusORCID, Rommelfanger Karen SORCID, Schwingenshuh PetraORCID, Serranova TerezaORCID, Shotbolt PaulORCID, Stebbins Glenn TORCID, Stone JonORCID, Tijssen Marina AJORCID, Tinazzi MicheleORCID, Nicholson Timothy RORCID
Abstract
ObjectivesWe aimed to identify existing outcome measures for functional neurological disorder (FND), to inform the development of recommendations and to guide future research on FND outcomes.MethodsA systematic review was conducted to identify existing FND-specific outcome measures and the most common measurement domains and measures in previous treatment studies. Searches of Embase, MEDLINE and PsycINFO were conducted between January 1965 and June 2019. The findings were discussed during two international meetings of the FND-Core Outcome Measures group.ResultsFive FND-specific measures were identified—three clinician-rated and two patient-rated—but their measurement properties have not been rigorously evaluated. No single measure was identified for use across the range of FND symptoms in adults. Across randomised controlled trials (k=40) and observational treatment studies (k=40), outcome measures most often assessed core FND symptom change. Other domains measured commonly were additional physical and psychological symptoms, life impact (ie, quality of life, disability and general functioning) and health economics/cost–utility (eg, healthcare resource use and quality-adjusted life years).ConclusionsThere are few well-validated FND-specific outcome measures. Thus, at present, we recommend that existing outcome measures, known to be reliable, valid and responsive in FND or closely related populations, are used to capture key outcome domains. Increased consistency in outcome measurement will facilitate comparison of treatment effects across FND symptom types and treatment modalities. Future work needs to more rigorously validate outcome measures used in this population.
Funder
Ministry of Health, Czech Republic Royal College of Psychiatrists King's College London National Institute of Neurological Disorders and Stroke Michael J Fox Foundation National Institute for Health Research National Institutes of Health
Subject
Psychiatry and Mental health,Neurology (clinical),Surgery
Reference60 articles.
1. Current concepts in diagnosis and treatment of functional neurological disorders;Espay;JAMA Neurol,2018 2. Epidemiology;Carson;Handb Clin Neurol,2016 3. Pathogenesis and pathophysiology of functional (psychogenic) movement disorders;Baizabal-Carvallo;Neurobiol Dis,2019 4. Outcome measures for functional neurological disorder: a review of the theoretical complexities;Nicholson;J Neuropsychiatry Clin Neurosci
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|